1. Home
  2. CDE vs BIO Comparison

CDE vs BIO Comparison

Compare CDE & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$15.90

Market Cap

9.5B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$317.58

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
BIO
Founded
1928
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDE
BIO
Price
$15.90
$317.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$16.33
$358.50
AVG Volume (30 Days)
16.7M
164.7K
Earning Date
10-29-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$1,700,723,000.00
$2,557,500,000.00
Revenue This Year
$95.35
$1.77
Revenue Next Year
$35.11
$2.30
P/E Ratio
$21.49
N/A
Revenue Growth
68.28
N/A
52 Week Low
$4.58
$211.43
52 Week High
$23.62
$373.69

Technical Indicators

Market Signals
Indicator
CDE
BIO
Relative Strength Index (RSI) 49.13 50.96
Support Level $15.65 $311.81
Resistance Level $17.88 $328.07
Average True Range (ATR) 0.85 10.25
MACD 0.25 -0.18
Stochastic Oscillator 54.16 55.82

Price Performance

Historical Comparison
CDE
BIO

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: